Straumann Holding AG

SWX:STMN Stock Report

Market Cap: CHF 18.3b

Straumann Holding Valuation

Is STMN undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of STMN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: STMN (CHF114.05) is trading below our estimate of fair value (CHF123.22)

Significantly Below Fair Value: STMN is trading below fair value, but not by a significant amount.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for STMN?

Other financial metrics that can be useful for relative valuation.

STMN key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue7.6x
Enterprise Value/EBITDA27.2x
PEG Ratio3.6x

Price to Earnings Ratio vs Peers

How does STMN's PE Ratio compare to its peers?

The above table shows the PE ratio for STMN vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average36.8x
SOON Sonova Holding
27.7x9.9%CHF 16.7b
MOVE Medacta Group
52.8x20.0%CHF 2.5b
METN Metall Zug
24.9x7.3%CHF 553.5m
ALC Alcon
41.9x9.5%CHF 39.6b
STMN Straumann Holding
73.9x20.9%CHF 18.0b

Price-To-Earnings vs Peers: STMN is expensive based on its Price-To-Earnings Ratio (73.9x) compared to the peer average (36.8x).

Price to Earnings Ratio vs Industry

How does STMN's PE Ratio compare vs other companies in the European Medical Equipment Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a14.8%
 n/an/an/a
No. of CompaniesPE048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a14.8%
 n/an/an/a
No more companies

Price-To-Earnings vs Industry: STMN is expensive based on its Price-To-Earnings Ratio (73.9x) compared to the European Medical Equipment industry average (30.3x).

Price to Earnings Ratio vs Fair Ratio

What is STMN's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

STMN PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio74.4x
Fair PE Ratio48.2x

Price-To-Earnings vs Fair Ratio: STMN is expensive based on its Price-To-Earnings Ratio (73.9x) compared to the estimated Fair Price-To-Earnings Ratio (48.1x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst STMN forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCHF 114.90
CHF 134.06
+16.7%
18.4%CHF 175.00CHF 90.00n/a18
Jun ’25CHF 117.00
CHF 135.94
+16.2%
18.2%CHF 175.00CHF 90.00n/a18
May ’25CHF 123.00
CHF 138.67
+12.7%
18.4%CHF 175.00CHF 90.00n/a18
Apr ’25CHF 144.00
CHF 142.32
-1.2%
18.4%CHF 175.00CHF 90.00n/a19
Mar ’25CHF 142.75
CHF 134.22
-6.0%
17.7%CHF 168.00CHF 90.00n/a18
Feb ’25CHF 137.45
CHF 128.22
-6.7%
16.1%CHF 153.00CHF 90.00n/a18
Jan ’25CHF 135.60
CHF 125.34
-7.6%
15.1%CHF 150.00CHF 90.00n/a17
Dec ’24CHF 119.85
CHF 124.40
+3.8%
14.8%CHF 150.00CHF 90.00n/a17
Nov ’24CHF 105.60
CHF 131.99
+25.0%
16.8%CHF 167.00CHF 90.00n/a17
Oct ’24CHF 117.20
CHF 135.38
+15.5%
18.0%CHF 167.00CHF 90.00n/a16
Sep ’24CHF 133.85
CHF 136.82
+2.2%
17.7%CHF 167.00CHF 90.00n/a17
Aug ’24CHF 144.15
CHF 134.47
-6.7%
20.4%CHF 165.00CHF 82.00n/a17
Jul ’24CHF 145.15
CHF 133.76
-7.8%
21.1%CHF 165.00CHF 82.00CHF 112.7017
Jun ’24CHF 135.10
CHF 131.88
-2.4%
22.3%CHF 165.00CHF 82.00CHF 117.0016
May ’24CHF 133.65
CHF 124.87
-6.6%
21.4%CHF 160.00CHF 82.00CHF 123.0015
Apr ’24CHF 136.35
CHF 124.53
-8.7%
21.8%CHF 160.00CHF 82.00CHF 144.0015
Mar ’24CHF 123.95
CHF 120.43
-2.8%
21.2%CHF 158.00CHF 80.00CHF 142.7514
Feb ’24CHF 120.95
CHF 116.21
-3.9%
20.4%CHF 150.00CHF 80.00CHF 137.4514
Jan ’24CHF 105.60
CHF 119.00
+12.7%
18.7%CHF 150.00CHF 88.00CHF 135.6013
Dec ’23CHF 108.65
CHF 122.08
+12.4%
17.9%CHF 153.00CHF 90.00CHF 119.8512
Nov ’23CHF 95.18
CHF 129.29
+35.8%
23.9%CHF 205.00CHF 90.00CHF 105.6013
Oct ’23CHF 91.84
CHF 137.25
+49.4%
24.6%CHF 205.00CHF 90.00CHF 117.2011
Sep ’23CHF 104.55
CHF 147.50
+41.1%
18.2%CHF 205.00CHF 90.00CHF 133.8512
Aug ’23CHF 127.80
CHF 154.67
+21.0%
20.8%CHF 205.00CHF 90.00CHF 144.1512
Jul ’23CHF 115.30
CHF 157.38
+36.5%
22.4%CHF 205.00CHF 90.00CHF 145.1513

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.